Evaluation of New Anti-Infective Drugs for the Treatment of Urinary Tract Infection

Robert H. Rubin(Massachusetts General Hospital), Walter E. Stamm(University of Washington), Vincent T. Andriole(Yale New Haven Hospital), Eugene D. Shapiro(Yale University), Robert J. Davis(University of Verona)
Clinical Infectious Diseases
November 1, 1992
10.1093/clind/15.supplement_1.s216
Cited by 472

Related Papers

Voriconazole versus Amphotericin B for Primary Therapy of Invasive Aspergillosis
|New England Journal of Medicine|2002|3.3k
Reactivity of the Gold/Water Interface During Selective Oxidation Catalysis
|Science|2010|1.1k
Treatment of Acromegaly with the Growth Hormone–Receptor Antagonist Pegvisomant
|New England Journal of Medicine|2000|874
Selective oxidation of alcohols and aldehydes over supported metal nanoparticles
|Green Chemistry|2012|777
Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist
|The Lancet|2001|643